Clinical Trial

Necrotizing Soft Tissue Infections

Study acronym: SnapNSTI
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
SnapNSTI is an international, multicenter, time-bound prospective observational cohort study designed to characterize current epidemiology, management patterns, and outcomes of patients with necrotizing soft-tissue infections (NSTI). The primary objective is to estimate 90-day all-cause mortality and to evaluate the variability in management across centers. The study will also explore the association between clinical characteristics, treatments, and patient-reported outcomes.
Trial Details
NCT Number NCT07107555
Lead Sponsor European Society for Trauma and Emergency Surgery
Collaborators: University of Pennsylvania, Hospital del Mar Research Institute (IMIM), Hospital del Mar, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, University of Birmingham
Conditions Necrotizing Soft Tissue Infection, Fournier Gangrene, Sepsis, Surgical Infection, Soft Tissue Infections
Enrollment 480 participants
Start Date 2026-01-01
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-06